These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 31478263)

  • 1. PRMT1 potentiates chondrosarcoma development through activation of YAP activity.
    Chen C; Zhou H; Zhang X; Liu Z; Ma X
    Mol Carcinog; 2019 Dec; 58(12):2193-2206. PubMed ID: 31478263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SRY-Box transcription factor 9 triggers YAP nuclear entry via direct interaction in tumors.
    Qian H; Ding CH; Liu F; Chen SJ; Huang CK; Xiao MC; Hong XL; Wang MC; Yan FZ; Ding K; Cui YL; Zheng BN; Ding J; Luo C; Zhang X; Xie WF
    Signal Transduct Target Ther; 2024 Apr; 9(1):96. PubMed ID: 38653754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-494 inhibits cell proliferation and invasion of chondrosarcoma cells in vivo and in vitro by directly targeting SOX9.
    Li J; Wang L; Liu Z; Zu C; Xing F; Yang P; Yang Y; Dang X; Wang K
    Oncotarget; 2015 Sep; 6(28):26216-29. PubMed ID: 26317788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PRMT1 is a novel molecular therapeutic target for clear cell renal cell carcinoma.
    Wang J; Wang C; Xu P; Li X; Lu Y; Jin D; Yin X; Jiang H; Huang J; Xiong H; Ye F; Jin J; Chen Y; Xie Y; Chen Z; Ding H; Zhang H; Liu R; Jiang H; Chen K; Yao Z; Luo C; Huang Y; Zhang Y; Zhang J
    Theranostics; 2021; 11(11):5387-5403. PubMed ID: 33859753
    [No Abstract]   [Full Text] [Related]  

  • 5. The BET Bromodomain Inhibitor JQ1 Suppresses Chondrosarcoma Cell Growth via Regulation of YAP/p21/c-Myc Signaling.
    Zhang HT; Gui T; Sang Y; Yang J; Li YH; Liang GH; Li T; He QY; Zha ZG
    J Cell Biochem; 2017 Aug; 118(8):2182-2192. PubMed ID: 28059436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RARγ Downregulation Contributes to Colorectal Tumorigenesis and Metastasis by Derepressing the Hippo-Yap Pathway.
    Guo PD; Lu XX; Gan WJ; Li XM; He XS; Zhang S; Ji QH; Zhou F; Cao Y; Wang JR; Li JM; Wu H
    Cancer Res; 2016 Jul; 76(13):3813-25. PubMed ID: 27325643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PRMT1-dependent regulation of RNA metabolism and DNA damage response sustains pancreatic ductal adenocarcinoma.
    Giuliani V; Miller MA; Liu CY; Hartono SR; Class CA; Bristow CA; Suzuki E; Sanz LA; Gao G; Gay JP; Feng N; Rose JL; Tomihara H; Daniele JR; Peoples MD; Bardenhagen JP; Geck Do MK; Chang QE; Vangamudi B; Vellano C; Ying H; Deem AK; Do KA; Genovese G; Marszalek JR; Kovacs JJ; Kim M; Fleming JB; Guccione E; Viale A; Maitra A; Emilia Di Francesco M; Yap TA; Jones P; Draetta G; Carugo A; Chedin F; Heffernan TP
    Nat Commun; 2021 Jul; 12(1):4626. PubMed ID: 34330913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylation of C/EBPα by PRMT1 Inhibits Its Tumor-Suppressive Function in Breast Cancer.
    Liu LM; Sun WZ; Fan XZ; Xu YL; Cheng MB; Zhang Y
    Cancer Res; 2019 Jun; 79(11):2865-2877. PubMed ID: 31015230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of protein arginine-methyltransferase 1 in gliomagenesis.
    Wang S; Tan X; Yang B; Yin B; Yuan J; Qiang B; Peng X
    BMB Rep; 2012 Aug; 45(8):470-5. PubMed ID: 22917032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PRMT1 promotes pancreatic cancer growth and predicts poor prognosis.
    Song C; Chen T; He L; Ma N; Li JA; Rong YF; Fang Y; Liu M; Xie D; Lou W
    Cell Oncol (Dordr); 2020 Feb; 43(1):51-62. PubMed ID: 31520395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. YAP promotes tumorigenesis and cisplatin resistance in neuroblastoma.
    Yang C; Tan J; Zhu J; Wang S; Wei G
    Oncotarget; 2017 Jun; 8(23):37154-37163. PubMed ID: 28415761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PRMT1-mediated H4R3me2a recruits SMARCA4 to promote colorectal cancer progression by enhancing EGFR signaling.
    Yao B; Gui T; Zeng X; Deng Y; Wang Z; Wang Y; Yang D; Li Q; Xu P; Hu R; Li X; Chen B; Wang J; Zen K; Li H; Davis MJ; Herold MJ; Pan HF; Jiang ZW; Huang DCS; Liu M; Ju J; Zhao Q
    Genome Med; 2021 Apr; 13(1):58. PubMed ID: 33853662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PRMT1 regulates the tumour-initiating properties of esophageal squamous cell carcinoma through histone H4 arginine methylation coupled with transcriptional activation.
    Zhao Y; Lu Q; Li C; Wang X; Jiang L; Huang L; Wang C; Chen H
    Cell Death Dis; 2019 May; 10(5):359. PubMed ID: 31043582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ROCK2 deprivation leads to the inhibition of tumor growth and metastatic potential in osteosarcoma cells through the modulation of YAP activity.
    Zucchini C; Manara MC; Cristalli C; Carrabotta M; Greco S; Pinca RS; Ferrari C; Landuzzi L; Pasello M; Lollini PL; Gambarotti M; Donati DM; Scotlandi K
    J Exp Clin Cancer Res; 2019 Dec; 38(1):503. PubMed ID: 31878963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. hCAF1, a new regulator of PRMT1-dependent arginine methylation.
    Robin-Lespinasse Y; Sentis S; Kolytcheff C; Rostan MC; Corbo L; Le Romancer M
    J Cell Sci; 2007 Feb; 120(Pt 4):638-47. PubMed ID: 17264152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential targeting of YAP1 and p21 enhances the elimination of senescent cells induced by the BET inhibitor JQ1.
    Zhang HT; Gui T; Liu RX; Tong KL; Wu CJ; Li Z; Huang X; Xu QT; Yang J; Tang W; Sang Y; Liu W; Liu N; Ross RD; He QY; Zha ZG
    Cell Death Dis; 2021 Jan; 12(1):121. PubMed ID: 33495462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. lncRNA
    Li N; Yang G; Luo L; Ling L; Wang X; Shi L; Lan J; Jia X; Zhang Q; Long Z; Liu J; Hu W; He Z; Liu H; Liu W; Zheng G
    Clin Cancer Res; 2020 Apr; 26(7):1736-1748. PubMed ID: 31831555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein arginine methyltransferase 1 coordinates the epithelial-mesenchymal transition/proliferation dichotomy in gastric cancer cells.
    Zhang Y; Wang D; Zhang M; Wei H; Lu Y; Sun Y; Zhou M; Gu S; Feng W; Wang H; Zeng J; Gong A; Xu M
    Exp Cell Res; 2018 Jan; 362(1):43-50. PubMed ID: 29097184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PTEN lipid phosphatase inactivation links the hippo and PI3K/Akt pathways to induce gastric tumorigenesis.
    Xu W; Yang Z; Xie C; Zhu Y; Shu X; Zhang Z; Li N; Chai N; Zhang S; Wu K; Nie Y; Lu N
    J Exp Clin Cancer Res; 2018 Aug; 37(1):198. PubMed ID: 30134988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PRMT1 Is a Novel Regulator of Epithelial-Mesenchymal-Transition in Non-small Cell Lung Cancer.
    Avasarala S; Van Scoyk M; Karuppusamy Rathinam MK; Zerayesus S; Zhao X; Zhang W; Pergande MR; Borgia JA; DeGregori J; Port JD; Winn RA; Bikkavilli RK
    J Biol Chem; 2015 May; 290(21):13479-89. PubMed ID: 25847239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.